You have full text access to this Open Access content

Cancer Science

Cover image for Vol. 104 Issue 6

June 2013

Volume 104, Issue 6

Pages June cover–June cover, i–iii, 651–778

  1. COVER IMAGE

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. You have full text access to this Open Access content
  2. PRELIMINARY PAGE

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. You have full text access to this Open Access content
      Preliminary Page (pages i–ii)

      Version of Record online: 23 MAY 2013 | DOI: 10.1111/cas.2400

  3. IN THIS ISSUE

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. You have full text access to this Open Access content
      In This Issue (page iii)

      Version of Record online: 11 APR 2013 | DOI: 10.1111/cas.12151

  4. REVIEW ARTICLE

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. You have full text access to this Open Access content
  5. ORIGINAL ARTICLES

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. BASIC AND CLINICAL IMMUNOLOGY

      You have full text access to this Open Access content
    2. CARCINOGENESIS

      You have full text access to this Open Access content
      Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma (pages 663–671)

      Yu Zhu, Le Xu, Jianping Zhang, Wenping Xu, Yujun Liu, Hankun Yin, Tao Lv, Huimin An, Li Liu, Hongyong He, Heng Zhang, Jing Liu, Jiejie Xu and Zongming Lin

      Version of Record online: 29 MAR 2013 | DOI: 10.1111/cas.12134

    3. You have full text access to this Open Access content
    4. CELL, MOLECULAR, AND STEM CELL BIOLOGY

      You have full text access to this Open Access content
    5. You have full text access to this Open Access content
    6. You have full text access to this Open Access content
    7. You have full text access to this Open Access content
      Artemis-dependent DNA double-strand break formation at stalled replication forks (pages 703–710)

      Junya Unno, Masatoshi Takagi, Jinhua Piao, Masataka Sugimoto, Fumiko Honda, Daisuke Maeda, Mitsuko Masutani, Tohru Kiyono, Fumiaki Watanabe, Tomohiro Morio, Hirobumi Teraoka and Shuki Mizutani

      Version of Record online: 15 APR 2013 | DOI: 10.1111/cas.12144

    8. CLINICAL RESEARCH

      You have full text access to this Open Access content
      Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis (pages 711–717)

      Ikuo Sekine, Yoshihiko Segawa, Kaoru Kubota and Toshiaki Saeki

      Version of Record online: 16 APR 2013 | DOI: 10.1111/cas.12146

    9. You have full text access to this Open Access content
      Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial (pages 718–724)

      Clemens Giessen, Ruediger P. Laubender, Ludwig Fischer von Weikersthal, Andreas Schalhorn, Dominik P. Modest, Sebastian Stintzing, Michael Haas, Ulrich R. Mansmann and Volker Heinemann

      Version of Record online: 14 APR 2013 | DOI: 10.1111/cas.12148

    10. You have full text access to this Open Access content
      Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma (pages 725–731)

      Masahiko Tameda, Katsuya Shiraki, Kazushi Sugimoto, Suguru Ogura, Yuji Inagaki, Norihiko Yamamoto, Makoto Ikejiri, Yoshiyuki Takei, Masaaki Ito and Tsutomu Nobori

      Version of Record online: 21 APR 2013 | DOI: 10.1111/cas.12149

    11. DRUG DISCOVERY AND DELIVERY

      You have full text access to this Open Access content
    12. You have full text access to this Open Access content
      Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells (pages 740–749)

      Akihiko Takeuchi, Yasuhiko Yamamoto, Seiichi Munesue, Ai Harashima, Takuo Watanabe, Hideto Yonekura, Hiroshi Yamamoto and Hiroyuki Tsuchiya

      Version of Record online: 24 MAR 2013 | DOI: 10.1111/cas.12133

    13. You have full text access to this Open Access content
      Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2 (pages 750–759)

      Shanshan Wang, Yu Zhu, Hongyong He, Jing Liu, Le Xu, Heng Zhang, Haiou Liu, Weisi Liu, Yidong Liu, Deng Pan, Lin Chen, Qian Wu, Jiejie Xu and Jianxin Gu

      Version of Record online: 24 MAR 2013 | DOI: 10.1111/cas.12132

    14. PATHOLOGY

      You have full text access to this Open Access content
      Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue (pages 760–764)

      Marilla C. Pender-Cudlip, Karen J. Krag, David Martini, Jeanne Yu, Anthony Guidi, Sandy S. Skinner, Yu Zhang, Xiying Qu, Chengwei He, Yi Xu, Steven Y. Qian and Jing X. Kang

      Version of Record online: 19 MAR 2013 | DOI: 10.1111/cas.12129

    15. You have full text access to this Open Access content
      Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma (pages 765–772)

      Keiji Inoue, Hideo Fukuhara, Atsushi Kurabayashi, Mutsuo Furihata, Masayuki Tsuda, Keisuke Nagakawa, Hirofumi Fujita, Kozo Utsumi and Taro Shuin

      Version of Record online: 17 APR 2013 | DOI: 10.1111/cas.12147

  6. REPORT

    1. Top of page
    2. COVER IMAGE
    3. PRELIMINARY PAGE
    4. IN THIS ISSUE
    5. REVIEW ARTICLE
    6. ORIGINAL ARTICLES
    7. REPORT
    1. You have full text access to this Open Access content

SEARCH

SEARCH BY CITATION